Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy

被引:21
|
作者
Talai, Aron S. [1 ]
Sedlacik, Jan [2 ]
Boelmans, Kai [3 ]
Forkert, Nils D. [1 ]
机构
[1] Univ Calgary, Hotchkiss Brain Inst, Dept Radiol, Calgary, AB, Canada
[2] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany
[3] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany
关键词
Support vector machines; Diffusion-tensor magnetic resonance imaging; Computer-Assisted Image Analysis; Parkinson's disease; Progressive supranuclear palsy; SUPPORT VECTOR MACHINE; MULTIPLE SYSTEM ATROPHY; CLINICAL-DIAGNOSIS; WEIGHTED MRI; VARIANT; COEFFICIENT; CLASSIFICATION; DEGENERATION; REGISTRATION;
D O I
10.1016/j.nicl.2018.09.028
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background: Parkinson's disease (PD) and progressive supranuclear palsy - Richardson's syndrome (PSP-RS) are often represented by similar clinical symptoms, which may challenge diagnostic accuracy. The objective of this study was to investigate and compare regional cerebral diffusion properties in PD and PSP-RS subjects and evaluate the use of these metrics for an automatic classification framework. Material and methods: Diffusion-tensor MRI datasets from 52 PD and 21 PSP-RS subjects were employed for this study. Using an atlas-based approach, regional median values of mean diffusivity (MD), fractional anisotropy (FA), radial diffusivity (RD), and axial diffusivity (AD) were measured and employed for feature selection using RELIEFF and subsequent classification using a support vector machine. Results: According to RELIEFF, the top 17 diffusion values consisting of deep gray matter structures, the brainstem, and frontal cortex were found to be especially informative for an automatic classification. A MANCOVA analysis performed on these diffusion values as dependent variables revealed that PSP-RS and PD subjects differ significantly (p < .001). Generally, PSP-RS subjects exhibit reduced FA, and increased MD, RD, and AD values in nearly all brain structures analyzed compared to PD subjects. The leave-one-out cross-validation of the support vector machine classifier revealed that the classifier can differentiate PD and PSP-RS subjects with an accuracy of 87.7%. More precisely, six PD subjects were wrongly classified as PSP-RS and three PSP-RS subjects were wrongly classified as PD. Conclusion: The results of this study demonstrate that PSP-RS subjects exhibit widespread and more severe diffusion alterations compared to PD patients, which appears valuable for an automatic computer-aided diagnosis approach.
引用
收藏
页码:1037 / 1043
页数:7
相关论文
共 50 条
  • [41] The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease
    Hardman, CD
    Halliday, GM
    EXPERIMENTAL NEUROLOGY, 1999, 158 (01) : 135 - 142
  • [42] Improved Automatic Morphology-Based Classification of Parkinson’s Disease and Progressive Supranuclear Palsy
    Aron S. Talai
    Zahinoor Ismail
    Jan Sedlacik
    Kai Boelmans
    Nils D. Forkert
    Clinical Neuroradiology, 2019, 29 : 605 - 614
  • [43] Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report
    Araki, Kunihiko
    Sumikura, Hiroyuki
    Matsudaira, Takashi
    Sugiura, Akira
    Takao, Masaki
    Murayama, Shigeo
    Obi, Tomokazu
    NEUROPATHOLOGY, 2016, 36 (02) : 187 - 191
  • [44] Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy
    Federico, F
    Simone, IL
    Lucivero, V
    DeMari, M
    Giannini, P
    Iliceto, G
    Mezzapesa, DM
    Lamberti, P
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (03) : 239 - 242
  • [45] Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy
    Guevara, C. A.
    Blain, C. R.
    Stahl, D.
    Lythgoe, D. J.
    Leigh, P. N.
    Barker, G. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (09) : 1193 - 1202
  • [46] The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease
    Somme, Johanne
    Carlos Gomez-Esteban, Juan
    Tijero, Beatriz
    Berganzo, Koldo
    Lezcano, Elena
    Jose Zarranz, Juan
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (08) : 1230 - 1233
  • [47] Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy
    Sachin, S.
    Shukla, G.
    Goyal, V.
    Singh, S.
    Aggarwal, Vijay
    Gureshkumar
    Behari, M.
    NEUROLOGY INDIA, 2008, 56 (02) : 122 - 126
  • [48] Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
    Mitchell, Trina
    Wilkes, Bradley J.
    Archer, Derek B.
    Chu, Winston T.
    Coombes, Stephen A.
    Lai, Song
    McFarland, Nikolaus R.
    Okun, Michael S.
    Black, Mieniecia L.
    Herschel, Ellen
    Simuni, Tanya
    Comella, Cynthia
    Afshari, Mitra
    Xie, Tao
    Li, Hong
    Parrish, Todd B.
    Kurani, Ajay S.
    Corcos, Daniel M.
    Vaillancourt, David E.
    NEUROIMAGE-CLINICAL, 2022, 34
  • [49] Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging
    Tsukamoto, Kazumichi
    Matsusue, Eiji
    Kanasaki, Yoshiko
    Kakite, Suguru
    Fujii, Shinya
    Kaminou, Toshio
    Ogawa, Toshihide
    NEURORADIOLOGY, 2012, 54 (09) : 947 - 955
  • [50] Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal Syndrome
    Khosousi, Shervin
    Hye, Abdul
    Velayudhan, Latha
    Bloth, Bjorn
    Tsitsi, Panagiota
    Markaki, Ioanna
    Svenningsson, Per
    PARKINSONISM & RELATED DISORDERS, 2023, 108